Last reviewed · How we verify
NCT04898972: MIND
Mindfulness-based Intervention in COPD Dyads
NA trial testing Mindfulness-based stress reduction intervention in Chronic Obstructive Pulmonary Disease in 80 participants. Status unknown.
30 December 2023
Quick facts
| Lead sponsor | Campus Bio-Medico University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 20 April 2021 |
| Primary completion | 30 December 2023 |
| Estimated completion | 30 December 2023 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Mindfulness-based stress reduction intervention
- Information on stress reduction
Conditions studied
- Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →
Sponsor
Campus Bio-Medico University
Who can join
18 and older, any sex, with Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the effectiveness of a Mindfulness-Based Stress Reduction intervention (MBSRI) on the reduction of stress, anxiety, and depression in people with COPD and their family caregivers. The experimental group will receive the MBSRI and the control group an informational intervention on stress management.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Impact of Anxiety and Depression in Chronic Obstructive Pulmonary Disease.
Rahi MS, Thilagar B, Balaji S, Prabhakaran SY, et al · · 2023 · cited 70× · PMID 36960961 · DOI 10.3390/arm91020011
Verify or expand the search:
- PubMed search for NCT04898972
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mindfulness-based stress reduction intervention
Trials testing the same drug.
- NCT06025799 — Effect of Mindfulness-based Stress Reduction Intervention on Psychological Distress and Hope Among Female Patients Under · NA · completed
Other recruiting trials for Chronic Obstructive Pulmonary Disease
Currently open trials in the same condition.
- NCT06749262 — Inclined Versus Standard Exercise for COPD Patients · NA · recruiting
- NCT07406659 — Different Inspiratory Muscle Trainings in Patients With COPD · NA · recruiting
- NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
- NCT07418736 — A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease · Phase 2 · recruiting
- NCT07069829 — Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo · recruiting
Other Campus Bio-Medico University trials
Trials by the same sponsor.
- NCT07448350 — TENS for Restoring Somatotopic Sensory Feedback in Lower Limb Amputees and Improving Phantom Limb Perception · NA · not yet recruiting
- NCT06860841 — Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM · Phase 4 · active not recruiting
- NCT06834269 — Transcranial Static Magnetic Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis. · NA · recruiting
- NCT06098040 — Long-Term Feedback Effect of FGM in Newly-Diagnosed T2D Patients · NA · active not recruiting
- NCT05842148 — Quality of Life After Conservative Oncoplastic Surgery in Breast Cancer Patients (IRONY: lIfe afteR ONcoplastic surgerY) · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04898972 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Campus Bio-Medico University
- Last refreshed: 3 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04898972.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing